| Safety and Immunogenicity of V116 in Adults Living With Human Immunodeficiency Virus (HIV) (V116-007, STRIDE-7) (NCT05393037) | Merck Sharp & Dohme LLC | 2022-07-13 |
| Safety and Immunogenicity of 20vPnC in Toddlers With 2 Prior Doses of Prevenar 13 (NCT05408429) | Pfizer | 2022-06-24 |
| 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan (NCT04875533) | Pfizer | 2021-06-14 |
| Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2 (NCT04887948) | Pfizer | 2021-05-20 |
| Safety and Immunogenicity of V114 in Healthy Infants in South Korea (V114-036) (NCT04633226) | Merck Sharp & Dohme LLC | 2021-02-10 |
| Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age (NCT04642079) | Pfizer | 2020-12-04 |
| A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator (NCT04525599) | Affinivax, Inc. | 2020-09-22 |
| 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants (NCT04530838) | Pfizer | 2020-09-16 |
| 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy Infants (NCT04546425) | Pfizer | 2020-09-09 |
| Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age (NCT04526574) | Pfizer | 2020-09-01 |
| 20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants (NCT04379713) | Pfizer | 2020-05-21 |
| 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants (NCT04382326) | Pfizer | 2020-05-20 |
| Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults (NCT03828617) | Pfizer | 2019-02-14 |
| Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination (NCT03835975) | Pfizer | 2019-02-12 |
| A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine (NCT03803202) | GlaxoSmithKline | 2019-01-24 |
| Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults (NCT03760146) | Pfizer | 2018-12-12 |
| Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants (NCT02308540) | PATH | 2015-01-12 |
| Nasopharyngeal Carriage Study in Healthy Kenyan Toddlers (NCT02146365) | PATH | 2014-09-25 |
| Post Market Surveillance to Observe Safety of Prevenar13™ in Adults (NCT01834222) | Pfizer | 2013-12-01 |
| Hepatitis B Vaccination in Infants (NCT01896596) | Public Health England | 2013-07-01 |
| A Phase III Clinical Trial to Study the Safety and Immunogenicity of Pneumovax™ 23 (V110) in Participants From the Russian Population (V110-018) (NCT01734239) | Merck Sharp & Dohme LLC | 2013-06-03 |
| Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines (NCT01432158) | University of Oxford | 2012-01-01 |
| Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos (NCT01396434) | Pfizer | 2011-12-01 |
| Child Pneumococcal Serotype Epidemiology In Greece (NCT01111214) | Pfizer | 2011-11-01 |
| A Study to Assess the Antibody Response of Healthy Chinese Children Who Have Been Vaccinated Previously With 4-doses of Prevenar (a Pneumococcal Vaccine) as Babies and Toddlers (NCT01298544) | Pfizer | 2010-11-01 |
| Postlicensure Observational Safety Study of 13vPnC Administered to Infants and Toddlers (NCT01128426) | Pfizer | 2010-06-01 |
| 13 Valent Pneumococcal Conjugate Vaccine - Follow-on Study (NCT01095471) | University of Oxford | 2010-04-01 |
| Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years (NCT00843895) | King Saud University | 2009-03-01 |
| Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children. (NCT00743652) | Pfizer | 2009-01-01 |
| Disease Burden of Pneumonia, Meningitis and Bacteremia Among Children in Japan: Pneumonet Japan (NCT00757575) | Pfizer | 2008-02-01 |
| A Study to Assess the Impact of Pneumococcal Conjugate Vaccination Programme on the Carriage of Pneumococci (NCT01040143) | Public Health England | 2008-01-01 |
| Pneumoniae Epidemiology Study in China (NCT00471770) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-02-01 |
| Study Evaluating Prevenar in High-Risk Children (NCT00234338) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-10-01 |